Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Journal of Proteome Research|April 19, 2012
Toward the reliable diagnosis of indeterminate thyroid lesions: a HRMAS NMR-based metabolomics case of studyLiborio Torregrossa, Laetitia Shintu, Jima Nambiath Chandran, et al.
Oncotarget|March 9, 2018
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastasesCristina Romei, Raffaele Ciampi, Francesca Casella, et al.
Cancer Cytopathology|January 11, 2016
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysisNicla Borrelli, Clara Ugolini, Riccardo Giannini, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2016
Papillary Thyroid Carcinoma With Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution ExperienceLiborio Torregrossa, David Viola, Elisa Sensi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 26, 2013
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancerValentina De Falco, Preziosa Buonocore, Magesh Muthu, et al.
Endocrine Connections|January 21, 2021
RET mutated C-cells proliferate more rapidly than non-mutated neoplastic cellsCristina Romei, Teresa Ramone, Chiara Mulè, et al.
Journal of Clinical Medicine|November 25, 2023
BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature ReviewAntonio Matrone, Fabrizia Citro, Carla Gambale, et al.
Pageof 13